Coalition For Epidemic Preparedness Innovations Formally Launched At WEF With $460M In Investments

The Atlantic: A Global Plan to Defend Against the Future’s Deadliest Diseases
“…[Outbreaks like the Ebola epidemic won’t happen again] if a new international coalition called CEPI — the Coalition for Epidemic Preparedness Innovations — has its way. CEPI (pronounced ‘seppy’) is a global vaccine-development fund, devoted to readying pandemic defenses during peacetime. With $460 million from the Wellcome Trust, the Bill & Melinda Gates Foundation, and the governments of Germany, Japan, and Norway, it will fund the development of vaccines against the likely pandemics of the future, testing them as far as possible, and stockpiling millions of doses. When outbreaks happen, the vaccines will be immediately ready for field-testing and mass-manufacture…” (Yong, 1/18).

Bloomberg: Gates Foundation Joins New $460 Million Coalition for Vaccines
“… ‘We have to be ready for a surprise, and that’s why our goal is really platform development,’ said Bill Gates, co-chairman of the foundation, in an interview with Bloomberg in Davos…” (Greifeld/Bass, 1/18).

Bloomberg: Ebola, Zika Push Drugmakers Into Effort to Avert Pandemics
“…Glaxo, the U.K.’s biggest drugmaker, is willing to commit scientists and technology to a proposed biopreparedness facility focused on vaccines that’s estimated to cost $40 million to $50 million a year, Chief Executive Officer Andrew Witty said in a telephone interview…” (Paton, 1/19).

Financial Times: Davos launch for coalition to prevent epidemics of emerging viruses
“…The founding partners expect other donors, including the U.S., U.K., E.U., and India, to provide enough money to make a total of $1bn available for more than five years. Vaccine manufacturers have also expressed enthusiasm about taking part…” (Cookson/Bradshaw, 1/18).

The Guardian: $460m pledged for vaccine initiative aimed at preventing global epidemics
“…Three diseases will initially be targeted: Lassa, MERS, and Nipah. All three are caused by viruses that have come from animals to infect humans and could trigger dangerous global epidemics…” (Boseley, 1/18).

Nature: Billion-dollar project aims to prep vaccines before epidemics hit
“…For the three diseases initially targeted, the CEPI aims to have stockpiles by 2021…” (Butler, 1/18).

New York Times: Donors and Drug Makers Offer $500 Million to Control Global Epidemics
“…The announcement was welcomed by Dr. Anthony S. Fauci, director of the National Institute of Allergy and Infectious Diseases, which designs vaccines but must partner with private industry to produce large amounts…” (McNeil, 1/18).

Quartz: A global alliance is investing $500 million to stop the spread of deadly outbreaks we are utterly unprepared for
“…CEPI has signed a memorandum of understanding with the WHO. The alliance will rely on the expertise of the global health body to guide their work…” (Rathi, 1/18).

Reuters: Global coalition aims to outpace epidemics with new vaccines
“…John-Arne Rottingen, interim chief executive officer of the Coalition for Epidemic Preparedness Innovations (CEPI), said it is designed as ‘a global insurance policy against epidemic and pandemic threats’…” (Kelland, 1/18).

ScienceInsider: A half-billion-dollar bid to develop vaccines against the next viral threat
“…CEPI will now solicit proposals from academic researchers and industry to develop candidate vaccines for its three target viruses. In five years, it aims to take two vaccines for each virus through early human studies so that they’re in the wings and ready for a real-world test as soon as one of these viruses surfaces again…” (Cohen, 1/18).

STAT: Remembering Ebola, coalition targets three viruses with outbreak potential
“…The announcement was made at the World Economic Forum in Davos, Switzerland. It was at that annual gathering last year that the creation of CEPI, as the organization is called, was announced…” (Branswell, 1/18).

Wall Street Journal: New Initiative Aims to Develop Epidemic-Targeting Vaccines
“…While the initiative won’t turn vaccines into a major moneymaker, it will aim to prevent the financial losses and disruption that occur when pharmaceutical companies must drop other projects to quickly concoct a vaccine, said [GSK CEO] Andrew Witty…” (McKay, 1/18).

Washington Post: New global coalition launched to create vaccines, prevent epidemics
“…Global health experts welcomed the initiative, saying it would complement efforts already underway by the World Health Organization and the U.S. Biomedical Advanced Research and Development Authority (BARDA), part of the Department of Health and Human Services, which are working on Ebola and Zika vaccines. The United States is not providing funding for CEPI, but it is offering subject expertise…” (Sun, 1/18).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.